Cost-effectiveness analysis of the treatment of large leiomyomas: laparoscopic assisted vaginal hysterectomy versus abdominal hysterectomy.

Cost-effectiveness analysis of the treatment of large leiomyomas: laparoscopic assisted vaginal hysterectomy versus abdominal hysterectomy.

Mittapalli R; Fanning J; Flora R; Fenton BW

American Journal of Obstetrics & Gynecology

2007

2007-05

OBJECTIVE: The purpose of this study was to perform a cost-effectiveness analysis comparing the treatment of large leiomyomas by laparoscopic assisted vaginal hysterectomy (LAVH) versus abdominal hysterectomy (AH). STUDY DESIGN: Twenty consecutive LAVH were compared to 20 consecutive AH for leiomyoma \textgreater or = 250 g. Hospital costs were obtained through Healthcare cost accounting system. The 6 principles of cost-effectiveness analysis were used. RESULTS: The groups were similar in respect to age, weight, race, medical comorbidities, blood loss, and operative time. Median uterine weight (513 g) was approximately 20% \textgreater for LAVH. Length of stay and pain was significantly less for LAVH. Total hospital cost for AH was approximately 12% less expensive ($4394 vs $5023, P = .18). CONCLUSION: Because of multiple benefits of LAVH versus AH and no significant difference in cost, we believe LAVH is an acceptable treatment for large leiomyoma.

Adult; Female; Aged; Hysterectomy; Costs and Cost Analysis; Human; Middle Age; Cost Benefit Analysis; Visual Analog Scaling; Health Facility Costs; 80 and Over; Leiomyoma – Surgery; Hysterectomy – Economics; Laparoscopy – Economics; Uterine Neoplasms – Surgery; Vaginal – Economics

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

e19–21

5

196